Current concepts of autoimmune exocrinopathy: Immunologic mechanisms in the salivary pathology of Sjogren's syndrome

Critical Reviews in Oral Biology and Medicine

Volumn 7, Issue 2, 1996, Pages 144-158

  Fox, P C ^a   Speight, P M ^b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

cytokines; immunology; salivary glands; Sjogren's syndrome

Indexed keywords

AUTOANTIBODY; CELL ADHESION MOLECULE; CYTOKINE; GROWTH FACTOR; INTERFERON;

AUTOIMMUNITY; CELL INFILTRATION; CELL LOSS; EXOCRINE SECRETION; HUMAN; MONOCLONAL IMMUNOGLOBULINEMIA; MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND DISEASE; SALIVATION DISORDER; SECRETORY CELL; SJOEGREN SYNDROME;

EID: 0029819151     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/10454411960070020301     Document Type: Review

References (111)

1. Adamson TC, Fox RI, Frisman DM, Howell FV (1983). Immunohistologic analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J Immunol 130:203-208.
2. Alpert S, Kang H, Weissman I, Fox RI (1994). Expression of granzyme A in salivary gland biopsies from patients with primary Sjögren's syndrome. Arthritis Rheum 37:1046-1054.
3. Anderson LG, Cummings NA, Asofsky R, Hylton MB, Tarpley TM Jr, Tomasi TB Jr, et al. (1972). Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome. Am J Med 53:456-463.
4. Atkinson JC, Travis WD, Pillemer SR, Bermudez D, Wolff A, Fox PC (1990). Major salivary gland function in primary Sjögren's syndrome and its relationship to clinical features. J Rheumatol 17:318-322.
5. Atkinson JC, Royce LS, Wellner R, Pillemer SR, Bermudez D, Fox PC (1995). Anti-salivary antibodies in Sjögren's syndrome. J Oral Pathol Med 24:206-212.
6. Aziz KE, McCluskey PJ, Montanaro A, Wakefield D (1992). Vascular endothelium and lymphocyte adhesion molecules in minor salivary glands of patients with Sjögren's syndrome. J Clin Lab Immunol 37:39-49.
7. Bateman AC, Wright DH (1993). Epitheliotropism in high-grade lymphomas of mucosa-associated lymphoid tissue. Histopathol 23:409-415.
8. Bodeutsch C, de Wilde PCM, Kater L, Hené RJ, van den Hoogen FHJ, van de Putte LBA, et al. (1992). Labial salivary gland biopsy in Sjögren's syndrome. Netherland J Med 40:148-157.
9. Bodeutsch C, de Wilde PCM, Kater L, van den Hoogen FH, Hené RJ, van Houwelingen JC, et al. (1993). Monotypic plasma cells in labial salivary glands of patients with Sjögren's syndrome: prognosticator for systemic lymphoproliferative disease. J Clin Pathol 46:123-128.
10. Bunim JJ, Talal N (1963). The association of malignant lymphoma with Sjögren's syndrome. Trans Assoc Am Phys 76:45-56.
11. Cattaneo R, Tosoni C, Franzini M, Manca N, Gelmi M, Turano A, et al. (1993). Antibodies to retroviral proteins in Sjögren's syndrome. Ann Rheum Dis 52:621.
12. Cauli A, Yanni G, Pitzalis C, Challacombe S, Panayi GS (1995). Cytokine and adhesion molecule expression in the minor salivary glands of patients with Sjögren's syndrome and chronic sialoadenitis. Ann Rheum Dis 54:209-215.
13. Daniels TE (1984). Labial salivary gland biopsy in Sjögren's syndrome: Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 27:147-156.
14. Daniels TE (1996). Sjögren's syndrome: Clinical spectrum and current diagnostic controversies. Adv Dent Res 10: 3-8.
15. De Vita S, Ferraccioli G, de Re V, Dolcetti R, Carbone A, Bartoli E (1994). The polymerase chain reaction detects B cell clonalities in patients with Sjögren's syndrome and suspected malignant lymphoma. J Rheumatol 21:1497-1501.
16. Deacon EM, Matthews JB, Potts AJC, Hamburger J, Mageed RA, Jefferis R (1991). Expression of rheumatoid factor associated cross-reactive idiotopes by glandular B cells in Sjögren's syndrome. Clin Exp Immunol 83:280-285.
17. Diss TC, Peng H, Wotherspoon AC, Pan L, Speight PM, Isaacson PG (1993). A single neoplastic clone in sequential biopsy specimens from a patient with primary gastric mucosa-associated lymphoid-tissue lymphoma and Sjögren's syndrome. N Engl J Med 329:172-175.
18. Diss TC, Wotherspoon AC, Speight PM, Pan L, Isaacson PG (1995). B-cell monoclonality, Epstein Barr virus and t(14;18) in myoepithelial sialadenitis and low-grade B-cell MALT lymphoma of the parotid gland. Am J Surg Pathol 19:531-536.
19. Edwards JC, Wilkinson LS, Speight P, Isenberg DA (1993). Vascular cell adhesion molecule 1 and alpha 4 and beta 1 integrins in lymphocyte aggregates in Sjögren's syndrome and rheumatoid arthritis. Ann Rheum Dis 52:806-811.
20. Eguchi K, Matsuoka N, Ida H, Nakashima M, Sakai M, Sakito S, et al. (1992). Primary Sjögren's syndrome with antibodies to HTLV-1: Clinical and laboratory features. Ann Rheum Dis 51:769-776.
21. Falzon M, Isaacson PG (1991). The natural history of benign lymphoepithelial lesions of the salivary gland in which there is a monoclonal population of B cells. Am J Surg Pathol 15:59-65.
22. Fishleder A, Tubbs R, Hesse B, Levine H (1987). Uniform detection of immunoglobulin gene rearrangement in benign lymphoepithelial lesions. N Engl J Med 316:1118-1121.
23. Fox PC (1985). Simplified biopsy techique for labial minor salivary glands. Plastic Reconstruct Surg 75:592-593.
24. Fox PC, Grisius M, Bermudez D, Sun D (1995). IL-6 in primary Sjögren's syndrome and a human salivary cell line (abstract). Clin Rheumatol 14(Suppl 1):44.
25. Fox RI, Saito I (1994). Sjögren's syndrome: immunologic and neuroendocrine mechanisms. In: Lacrimal gland, tear film, and dry eye syndromes. Sullivan DA, editor. New York: Plenum Press, pp. 609-621.
26. Fox RI, Hugli TE, Lanier LL, Morgan EL, Howell F (1985a). Salivary gland lymphocytes in primary Sjögren's syndrome lack lymphocyte subsets defined by leu-7 and leu-11 antigens. J Immunol 135:207-214.
27. Fox RI, Theofilopoulos AN, Altman A (1985b). Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL 2. J Immunol 135:3109-3115.
28. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV (1986a). Sjögren's syndrome: Proposed criteria for classification. Arthritis Rheum 29:577-585.
29. Fox RI, Chen P, Carson DA, Fong S (1986b). Expression of cross-reactive idiotype on rheumatoid factor in patients with Sjögren's syndrome. J Immunol 136:477-483.
30. Fox RI, Luppi M, Kang H, Pisa P (1991). Reactivation of Epstein-Barr virus in Sjögren's syndrome. Springer Sem Immunopathol 13:217-231.
31. Fox RI, Luppi M, Pisa P, Kang H (1992). Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis. J Rheumatol 19(Suppl 32):18-24.
32. Fox RI, Luppi M, Kang HHI, Ablshi D, Josephs S (1993). Detection of high levels of human herpes virus-6 DNA in a lymphoma of a patient with Sjögren's syndrome (letter). J Rheumatol 20:764-765.
33. Fox RI, Kang H, Ando D, Abrams J, Pisa E (1994). Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 152:5532-5539.
34. Freimark B, Fantozzi R, Bone R, Bordin G, Fox R (1989). Detection of clonally expanded salivary gland lymphocytes in Sjögren's syndrome. Arthritis Rheum 32:859-869.
35. Garry R (1994). New evidence for involvement of retroviruses in Sjögren's syndrome and other autoimmune diseases (editorial). Arthritis Rheum 37:465-469.
36. Garry RF, Fermin CD, Hart DJ, Alexander SS, Donehower LA, Luo-Zhang H (1990). Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 250:1127-1129.
37. Gleeson MJ, Cawson RA, Bennett MH (1986). Benign lymphoepithelial lesion: a less than benign disease. Clin Otolaryngol 11:47-51.
38. Godwin JT (1952). Benign lymphoepithelial lesion of the parotid gland (adenolymphoma, chronic inflammation, lymphoepithelioma, lymphocytic tumor, Mikulicz disease): Report of eleven cases. Cancer 5:1089-1103.
39. Gorgoulis V, Giatromanolaki A, Iliopoulos A, Kanavaros P, Aninos D, Ioakeimidis D, et al (1993). EGF and EGF-r immunoexpression in Sjögren's syndrome secondary to rheumatoid arthritis. Correlation with EBV expression? Clin Exp Rheumatol 11:623-627.
40. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC (1992). Lymphocytic sialoadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 8:321-323.
41. Holm LE, Blomgren H, Lowhagen T (1985). Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 312:601-604.
42. Hyjek E, Smith WJ, Isaacson PG (1988). Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialoadenitis. Human Pathol 19:766-776.
43. Ichikawa Y, Shimizu H, Yoshida M, Takaya M, Arimori S (1992). Accessory molecules expressed on the peripheral blood or synovial fluid T lymphocytes from patients with Sjögren's syndrome or rheumatoid arthritis. Clin Exp Rheum 10:447-454.
44. Isaacson PG (1993). Lymphomas of mucosa associated lymphoid tissue (MALT-type lymphomas). Forum: Trends Exp Clin Med 3:234-245.
45. Isaacson PG, Spencer J (1993). Autoimmunity and malignancy. In: Autoimmune diseases. Isenberg DA, Horsfall AC, editors. Oxford: BIOS Scientific Publishers Ltd, pp. 189-201.
46. Isaacson PG, Wright DH (1984). Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 53:2515-2524.
47. Isenberg DA, Rowe D, Tookman A, Hopp A, Griffiths M, Paice E, et al. (1984). An immunohistological study of secondary Sjögren's syndrome. Ann Rheum Dis 43:470-476.
48. Jordan RCK, Pringle JH, Speight PM (1995a). High frequency of light chain restriction in labial gland biopsies of Sjögren's syndrome detected by in situ hybridization. J Pathol 177:35-40.
49. Jordan RCK, Diss TC, Lench J, Isaacson PG, Speight PM (1995b). Immunoglobulin gene rearrangements in lymphoplasmacytic infiltrates of labial salivary glands in Sjögren's syndrome: A possible predictor of lymphoma development. Oral Surg Oral Med Oral Pathol 79:723-729.
50. Jordan RCK, Odell EW, Speight PM (1996). B-cell monoclonality in salivary lymphoepithelial lesions. Oral Oncol Eur J Cancer 32(B):38-44.
51. Jorgensen JL, Esser U, de St Groth BF, Reay PA, Davis MM (1992). Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355:224-230.
52. Kapp A (1993). The role of cytokines in the psoriatic inflammation. J Derm Sci 5:133-142.
53. Karameris A, Gorgoulis V, Iliopoulos A, Frangia C, Kontomerkos T, Ioakeimidis D, et al. (1992). Detection of the Epstein-Barr viral genome by an in situ hybridization method in salivary gland biopsies from patients with secondary Sjögren's syndrome. Clin Exp Rheumatol 10:327-332.
54. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR (1978). Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89:888-892.
55. Katz J, Nagler R, Barak S, Livneh A, Baum B, Atkinson J, et al. (1994). Cytokines modulate interleukin-6 production by human salivary gland cell line. Cell Immunol 159:211-219.
56. Legras F, Martin T, Knapp A-M, Pasquali J-L (1994). Infiltrating T cells from patients with primary Sjögren's syndrome express restricted or unrestricted T cell receptor Vβ regions depending on the stage of the disease. Eur J Immunol 24:181-185.
57. Lindahl G, Hedfors E, Klareskog L, Forsum U (1985). Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome. Clin Exp Immunol 61:475-482.
58. Maddison PJ (1993). Autoantibodies in Sjögren's syndrome: their origins and pathological consequences. In: Autoimmune diseases. Isenberg DA, Horsfall AC, editors. Oxford: BIOS Scientific Publishers Ltd., pp. 89-98.
59. Manthorpe R, Oxholm P, Prause JU, Schiødt M (1986). The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol (Suppl 61):19-21.
60. Mariette X, Gozlan J, Clerc D, Bisson M, Morinet F (1991). Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome. Am J Med 90:286-294.
61. Mariette X, Zerbib M, Jaccard A, Schenmetzler C, Danon F (1993a). Hepatitis-C virus and Sjögren's syndrome. Arthritis Rheum 36:280-281.
62. Mariette X, Agbalika F, Daniel M, Bisson M, Lagrange P, Brouet J, et al. (1993b). Detection of human T lymphotropic virus type I tax gene in salivary gland epithelium from two patients with Sjögren's syndrome. Arthritis Rheum 36:1423-1428.
63. Marrone A, Di Bisceglie AM, Fox PC (1995). Absence of hepatitis C viral infection among patients with primary Sjögren's syndrome (brief report). J Hepatol 22:599.
64. Marson P, Ostuni PA, Vicarioto M, Ongaro G, Gambari PF (1991). Anti-hepatitis C virus serology in primary Sjögren's syndrome: No evidence of cross-reactivity between rheumatoid factor and specific viral proteins. Clin Exp Rheumatol 9:661-662.
65. Matthews JB, Deacon EM, Kitas GD, Salmon M, Potts AJC, Hamburger J, et al. (1991). Primed and naive helper T cells in labial glands from patients with Sjögren's syndrome. Virch Arch A Pathol Anat 419:191-197.
66. Matthews JB, Deacon EM, Wilson C, Potts AJC, Hamburger J (1993). Plasma cell populations in labial salivary glands from patients with and without Sjögren's syndrome. Histopathol 23:399-407.
67. Moutsopoulos HM, Steinberg AD, Fauci AS, Lanes HC, Papadopoulos NM (1983). High incidence of free monoclonal lambda light chains in the sera of patients with Sjögren's syndrome. J Immunol 130:2663-2665.
68. Moutsopoulos HM, Costello R, Drosos AA, Mavridis AK, Papadopoulos NM (1985). Demonstration and identification of monoclonal proteins in the urine of patients with Sjögren's syndrome. Ann Rheum Dis 44:109-112.
69. Moutsopoulos HM, Tzioufas AG, Bai MK, Papadopoulos NM (1990). Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands. Ann Rheum Dis 49:929-931.
70. Offner H, Hashim GA, Vandenbark AA (1991). T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251:430-432.
71. Oosterveer MA, Markusse HM, Lennette ET, Zou JZ, Bolhuis RL, Gratama JW (1993). Characterization of Epstein-Barr virus strains in parotid gland saliva and peripheral blood of patients with primary Sjögren's syndrome and healthy EBV carriers. J Med Virol 41:261-269.
72. Oxholm P, Daniels TE, Bendtzen K (1992). Cytokine expression in labial salivary glands from patients with primary Sjögren's syndrome. Autoimmunity 12:185-191.
73. Pavlidis NA, Drosos AA, Papdimitriou C, Talal N, Moutsopoulos HM (1992). Lymphoma in Sjögren's syndrome. Med Ped Oncol 20:279-283.
74. Pflugfelder SC, Crouse C, Pereira I, Atherton S (1990). Amplification of Epstein-Barr virus genomic sequences in blood cells, lacrimal glands, and tears from primary Sjögren's syndrome patients. Ophthalmol 97:976-084.
75. Picker LJ (1994). Control of lymphocyte homing. Curr Opin Immunol 6:394-406.
76. Pigott R, Power C (1993). The adhesion molecule facts book. London: Academic Press.
77. Rice GE, Munro JM, Bevilacqua MP (1990). Inducible cell adhesion molecule 110 (INCAM-110) is an inducible endothelial cell receptor for lymphocytes. J Exp Med 171:1369-1374.
78. Rowe D, Griffiths M, Stewart J, Novick D, Beverley PCL, Isenberg DA (1987). HLA class I and II, interferon, interleukin 2, and the interleukin 2 receptor expression on labial biopsy specimens from patients with Sjögren's syndrome. Ann Rheum Dis 46:580-586.
79. Saito I, Servenius B, Compton T, Fox RI (1989). Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren's syndrome. J Exp Med 169:2191-2198.
80. Saito I, Terauchi K, Shimuta M, Nishimura S, Yoshino K, Takeuchi T, et al. (1993). Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjögren's syndrome. J Clin Lab Anal 7:180-187.
81. Santana V, Rose WR (1992). Neoplastic lymphoproliferation in autoimmune disease: An updated review. Clin Immunol Immunopathol 63:205-213.
82. Schmid U, Helbron D, Lennert K (1982). Development of malignant lymphomas in myoepithelial sialadenitis (Sjögren's syndrome). Virch Arch A 395:11-43.
83. Shattles WG, Brookes SM, Venables PJW, Clark DA, Maini RN (1992). Expression of antigen reactive with a monoclonal antibody to HTLV-1 p19 in salivary glands in Sjögren's syndrome. Clin Exp Immunol 89:46-51.
84. Shin SS, Sheibani K, Fishleder A, Ben-Ezra J, Bailey A, Koo CH, et al. (1991). Monocytoid B-cell lymphoma in patients with Sjögren's syndrome: A clinicopathologic study of 13 patients. Human Pathol 22:422-430.
85. Skopouli FN, Fox PC, Galanopoulou V, Atkinson JC, Jaffe ES, Moutsopoulos HM (1991). T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome. J Rheumatol 18:210-214.
86. Speight PM, Jordan R (1993). The molecular pathology of Sjögren's syndrome. In: Autoimmune diseases. Isenberg DA, Horsfall AC, editors. Oxford: BIOS Scientific Publishers Ltd., pp. 25-38.
87. Speight PM, Cruchley A, Williams DM (1990). Quantification of plasma cells in labial salivary glands: increased expression of IgM in Sjögren's syndrome. J Oral Pathol Med 19:126-130.
88. Speight PM, Jordan R, Colloby P, Nandha H, Pringle JH (1994). Early detection of lymphomas in Sjögren's syndrome by in-situ hybridization for kappa and lambda light chain mRNA in labial salivary glands. Oral Oncol Eur J Cancer 30(B):244-247.
89. St Clair EW, Angellilo JC, Singer KH (1992). Expression of cell-adhesion molecules in the salivary gland microenvironment of Sjögren's syndrome. Arthritis Rheum 35:62-66.
90. Strand V, Talal N (1980). Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy). Bull Rheum Dis 30:1046-1052.
91. Sumida T, Yonaha F, Maeda T, Tanabe E, Koike T, Tomioka H, et al. (1992). T cell receptor repertoire of infiltrating T cells in lips of Sjögren's syndrome patients. J Clin Invest 89:681-685.
92. Sumida T, Yonaha F, Maeda T, Kita Y, Iwamoto I, Koike T, et al. (1994). Expression of sequences homologous to HTLV-1 tax gene in the labial salivary glands of Japanese patients with Sjögren's syndrome. Arthritis Rheum 37:545-550.
93. Talal N, Sokoloff L, Barth WF (1967). Extrasalivary lymphoid abnormalities in Sjögren's syndrome (reticulum-cell sarcoma, "pseudolymphoma", macroglobulinaemia). Am J Med 43:50-65.
94. Talal N, Asofsky R, Lightbody P (1970). Immunoglobulin synthesis by salivary gland lymphoid cells in Sjögren's syndrome. J Clin Invest 49:49-54.
95. Talal N, Dauphinee M, Dang H, Alexander S, Hart D, Garry R (1990). Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome. Arthritis Rheum 33:774-781.
96. Tateishi M, Saito I, Yamamoto K, Miyasaka N (1993). Spontaneous production of Epstein-Barr virus by B-lymphoblastoid cell lines obtained from patients with Sjögren's syndrome: Possible involvement of a novel strain of Epstein-Barr virus in disease pathogenesis. Arthritis Rheum 36:827-835.
97. Thornhill M, Wellicome SM, Hahiouz DL, Lanchbury JS, Kyan-Aung U, Haskard DO (1991). Tumour necrosis factor combines with Il-4 or interferon gamma to selectively enhance endothelial cell adhesiveness for T cells. J Immunol 146:592-598.
98. Tzioufas AG, Moutsopoulos HM, Talal N (1987). Lymphoid malignancy and monoclonal proteins. In: Sjögren's syndrome: Clinical and immunological aspects. Talal N, Moutsopoulos HM, Kassan SS, editors. New York: Springer-Verlag, pp. 129-136.
99. Urban JL, Kumar V, Kono DH, Gomez C, Horvath SJ, Clayton J, et al. (1988). Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577-592.
100. Venables PJ, Teo CG, Baboonian C, Griffin BE, Hughes RA (1989). Persistence of Epstein-Barr virus in salivary gland biopsies from healthy individuals and patients with Sjögren's syndrome. Clin Exp Immunol 75:359-364.
101. Vitali C, Sciuto M, Neri R, Greco F, Marridis AK, Tsioufas AG, et al. (1992). Anti-hepatitis C virus antibodies in primary Sjögren's syndrome: False-positive results are related to hypergammaglobulinaemia. Clin Exp Rheumatol 10:103-104.
102. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. (1993). Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36:340-347.
103. Walters MT, Stevenson FK, Herbert A, Cawley MID, Smith JL (1986). Urinary monoclonal free light chains in primary Sjögren's syndrome: an aid to the diagnosis of malignant lymphoma. Ann Rheum Dis 45:210-219.
104. Wilkinson LS, Edwards JCW, Poston R, Haskard DO (1993). Cell populations expressing VCAM-1 in normal and diseased synovium. Lab Invest 68:82-88.
105. Wolf H, Haus M, Wilmes E (1984). Persistence of Epstein-Barr virus in the parotid gland. J Virol 51:795-798.
106. Wraith DC, Smilek DE (1992). A role for major histocompatibility complex-binding peptides in the immunotherapy of autoimmune disease. Springer Sem Immunopathol 14:95-101.
107. Wraith DC, McDevitt HD, Steinman L, Acha-Orbea H (1989). T cell recognition as the target for immune intervention in autoimmune disease. Cell 57:709-715.
108. Wu AJ, Kurrasch RH, Katz J, Fox PC, Baum BJ, Atkinson JC (1994). Effect of tumor necrosis factor-α and interferon-γ on the growth of a human salivary cell line. J Cell Physiol 161:217-226.
109. Yamoaka K, Miyasaka N, Sato K, Okuda M, Nishioka K (1989). B cell hyperresponsiveness in Sjögren's syndrome. Autoimmunity 3:261-269.
110. Yonaha F, Sumida T, Maeda T, Tomioka H, Koike T, Yoshida S (1992). Restricted junctional usage of T cell receptor Vβ2 and Vβ13 genes, which are overrepresented on infiltrating T cells in the lips of patients with Sjögren's syndrome. Arthritis Rheum 35:1362-1367.
111. Zulman J, Jaffe R, Talal N (1978). Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med 299:1215-1220.